United States· US:68547-501_49438c9b-3fce-4f3b-b878-18a17bc62b2e
Giapreza
A angiotensin ii product containing angiotensin ii, registered in United States by La Jolla Pharmaceutical Company. The same ATC class is registered in 11 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Angiotensin ii is registered in 11 of 19 countries.
Countries holding a registration under ATC C01CX09 (angiotensin ii), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 7 of them publish a price we can compare per daily dose
Angiotensin ii · ATC C01CX09
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ANGIOTENSIN II
- Manufacturer
- La Jolla Pharmaceutical Company
- Country
- United States (US)
- ATC code
- C01CX09
- ATC class
- Angiotensin II
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- July 19, 2026
Packs & prices · 2
- ndc1168547-501-02
- ndc1168547501021 VIAL, SINGLE-DOSE in 1 CARTON (68547-501-02) / 1 mL in 1 VIAL, SINGLE-DOSE
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Angiotensin ii in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceGIAPREZA 2,5 mg/ml, solution à diluer pour perfusionPAION PHARMA (ALLEMAGNE)
- United KingdomGiapreza 2.5mg/1ml concentrate for solution for infusion vialsPAION Pharma GmbH
- IcelandGiaprezaPAION Pharma GmbH
- SpainGIAPREZA 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSIONPaion Pharma Gmbh
- NorwayGiaprezaPAION Pharma GmbH
- SwedenGIAPREZA 2,5 mg/ml Koncentrat till infusionsvätska, lösningPAION Pharma GmbH
- NetherlandsGiapreza 2,5 mg/ml concentraat voor oplossing voor infusiePaion Pharma GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Giapreza
- Liechtenstein · Giapreza
- Norway · Giapreza
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6565c3b0-0d58-4a2e-b45f-d2e129eb8bd2 GET /v1/drugs/6565c3b0-0d58-4a2e-b45f-d2e129eb8bd2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "2.5",
"substance": "ANGIOTENSIN II",
"productndc": "68547-501",
"dosage_form": "INJECTION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "NDA209360",
"marketing_category": "NDA"
}See everything about angiotensin ii.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.